San Antonio, June 20, 2012 (GLOBE NEWSWIRE) -- Keraplast Technologies, LLC the developer of ReplicineTM Functional Keratin®Advanced Wound care products announced today having entered an agreement with Gramatek Ltd, for distribution of their advanced wound care products to Hospitals and wound care centers throughout Turkey. Partnering with Gramatek provides Keraplast access to Hospitals, Clinics and strategic Points of service centers throughout key regional areas of Turkey, said Michael Espensen, CEO of Keraplast Technologies, LLC. "We are extremely pleased to enter into this agreement with such an esteemed organization and to provide members served by Gramatek with our paradigm changing line of Replicine™ Functional Keratin® products. Clinicians in many regions of the world, including the USA, Europe, Australia, New Zealand, South Africa, and now Turkey can utilize the latest clinical advancement in wound healing. The global interest in kerasorb®, keramatrix®, keragel™ and keragelT™ is expanding quickly and were putting in a strong network to provide good support wherever the products are in demand".
About Gramatek, a biomedical distributor of innovative wound care products based in Ankara, Turkey uses its extensive experience and network to bring the latest wound treatment solutions to the Turkish health sector. "With Keraplast not only did we find a very strong scientific team and organization, but also a company that carries in its portfolio unique and advanced wound treatment products which will prove to be very beneficial for the Turkish public. We are excited at the prospect of fruitful cooperation." said Ayten Boz, GM of Gramatek, Ltd.
About Keraplast, a privately held company founded in 1996, is the first and only commercial manufacturer of proprietary Bioactive Keratin products. Headquartered in San Antonio, Texas. Keraplast manufactures ReplicineTM Functional Keratin® wound care products with FDA and CE mark clearance for sale around the world, as well as a wide range of skin care, hair care and nutritional solutions using proprietary keratin technology.
CONTACT: Dr. Rob Kelly; Rob.Kelly@keraplast.com; 210-591-8573 William Moore; firstname.lastname@example.org; 210-494-5596